Addolorato G, Caputo F, Capristo E, Bernardi M, Stefanini GF, Gasbarrini G. (1999) A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration. Clin Neuropharmacol, 22:
60-62.
Anderson IB, Kim-Katz SY, Dyer JE, Earnest GE, Lamb JP, Blanc PD. (2009) Area- level socioeconomic status in relation to outcomes in gamma-hydroxybutyrate intoxication. Clin Toxicol (Phila), 2008 47: 48-57.
Andriamampandry C, Taleb O, Viry S, Muller C, Humbert JP, Gobaille S, Aunis D, Maitre M. (2003) Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB). FASEB J, 17: 1691- 1693.
Araque A, Li N, Doyle RT, Haydon PG. (2000) Snare protein dependent glutamate release from astrocytes. J Neurosci, 20: 666–673.
Arcuino G, Lin JH, Takano T, Liu C, Jiang L, Gao Q, Kang J, Nedergaard M.
Intercellular calcium signaling mediated by point-source burst release of ATP. Proc Natl Acad Sci U S A, 99: 9840-9845.
Banerjee PK, Liu CC, Snead OC 3rd. (1998) Steroid-inhibition of [3H]gamma- hydroxybutyric acid (GHB) binding in thalamic relay nuclei increases during absence seizures. Brain Res, 813: 343-350.
Barabás P, Kovács I, Kovács R, Pálhalmi J, Kardos J, Schousboe A. (2002) Light induced changes in glutamate release from isolated rat retina is regulated by cGMP. J Neurosci Res, 67: 149–155.
Barbaccia ML, Carai MA, Colombo G, Lobina C, Purdy RH, Gessa GL. (2005) Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines. Neuropharmacology, 49: 48-58.
Bar-Gad I, Heimer G, Ritov Y, Bergman H. (2003) Functional correlations between neighbouring neurons in the primate globus pallidus are weak or non existent. J Neurosci, 23: 4012-4016.
Baumbach L, Leyssac PP. Skinner SL. (1976) Studies on renin release from isolated superfused glomeruli: effects of temperature, urea, ouabain and ethacrynic acid. J Physiol, 258: 243–256.
Beghè F, Carpanini MT. (2000) Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependent patients. Alcohol, 20: 223-225.
Benavides J, Rumigny JF, Bourguignon JJ, Cash C, Wermuth CG, Mandel P, Vincendon G, Maitre M. (1982) High affinity binding sites for gamma- hydroxybutyric acid in rat brain. Life Sci, 30: 953-961.
Bennett MV, Contreras JE, Bukauskas FF, Sáez JC. (2003) New roles for astrocytes:
gap junction hemichannels have something to communicate. Trends Neurosci, 26:
610-617.
Bennett SA, Arnold JM, Chen J, Stenger J, Paul DL, Roberts DC. Long-term changes in connexin32 gap junction protein and mRNA expression following cocaine self administration in rats. Eur J Neurosci, 11: 3329-3338.
Bergersen LH, Gundersen V. (2009) Morphological evidence for vesicular glutamate release from astrocytes. Neuroscience, 158: 260-265
Bergmeyer HU. Methods of Enzymatic Analysis. Verlag Chemie, Weinheim, 1974.
Bernasconi R, Mathivet P, Bischoff S, Marescaux C. (1999) Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential? Trends Pharmacol Sci, 20: 135-141.
Berridge KC, Robinson TE. (2003) Parsing reward. Trends Neurosci, 26: 507-513.
Bessman SP, Fishbein WN, (1963) Gamma-hydroxybutyrate, a normal brain metabolite. Nature, 200: 1207-1208.
Bevans CG, Harris AL. (1999) Regulation of connexin channels by pH. Direct action of the protonated form of taurine and other aminosulfonates. J Biol Chem, 274:
3711-3719.
Bouyer JJ, Joh TH, Pickel VM. (1984) Ultrastructural localization of tyrosine hydroxylase in rat nucleus accumbens. J Comp Neurol, 227: 92-103.
Brancucci A, Berretta N, Mercuri NB, Francesconi W. (2004) Gamma- hydroxybutyrate and ethanol depress spontaneous excitatory postsynaptic currents in dopaminergic neurons of the substantia nigra. Brain Res, 997: 62-66.
Brog JS, Salyapongse A, Deutch AY, Zahm DS. (1993) The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum:
immunohistochemical detection of retrogradely transported fluoro-gold. J Comp Neurol, 338: 255-278.
Cammalleri MA, Brancucci A, Berton F, Loche A, Gessa GL, Francesconi W.
(2002) Gamma-hydroxybutyrate reduces GABA(A)-mediated inhibitory postsynaptic potentials in the CA1 region of hippocampus.
Neuropsychopharmacology, 27: 960-969.
Carai MA, Colombo G, Brunetti G, Melis S, Serra S, Vacca G, Mastinu S, Pistuddi AM, Solinas C, Cignarella G, Minardi G, Gessa GL. (2001) Role of GABA(B)
receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol, 428: 315-321.
Carai MAM, Lobina C, Maccioni P, Cabras C, Colombo G, Gessa GL. (2008) γ- Aminobutyric acidB (GABAB)-receptor mediation of different in vivo effects of γ- butyrolactone. J Pharmacol Sci, 106: 199-207.
Carlezon WA Jr, Thomas MJ. (2009) Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis. Neuropharmacology, 56 Suppl 1: 122-132.
Carter LP, Wu H, Chen W, Cruz CM, Lamb RJ, Koek W, Coop A, France CP.
(2004) Effects of gamma-hydroxybutyrate (GHB) on schedule-controlled responding in rats: role of GHB and GABAB receptors. J Pharmacol Exp Ther, 308: 182-188.
Carter LP, Wu H, Chen W, Cruz CM, Lamb RJ, Koek W, Coop A, France CP.
(2004) Effects of gamma-hydroxybutyrate (GHB) on schedule-controlled responding in rats: role of GHB and GABAB receptors. J Pharmacol Exp Ther, 308: 182-188.
Cash CD, Rumigny JF, Mandel P, Maitre M. (1981) Enzymology of the alternative reductive pathway of GABA catabolism leading to the biosynthesis of gamma- hydroxybutyrate. Adv Biochem Psychopharmacol, 29: 527-535.
Castelli MP, Ferraro L, Mocci I, Carta F, Carai MA, Antonelli T, Tanganelli S, Cignarella G, Gessa GL. (2003) Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid. J Neurochem, 87: 722–732.
Castelli MP, Mocci I, Langlois X, Gommerendagger W, Luyten WH, Leysen JE, Gessa GL. (2000) Quantitative autoradiographic distribution of gamma- hydroxybutyric acid binding sites in human and monkey brain. Brain Res Mol Brain Res, 78: 91–99.
Castelli MP, Mocci I, Pistis M, Peis M, Berta D, Gelain A, Gessa GL, Cignarella G.
(2002) Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate receptor in the rat brain. Eur J Pharmacol, 446: 1-5.
Castelli MP, Pibiri F, Carboni G, Piras AP. (2004) A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor.
CNS Drug Rev, 10: 243-260.
Chang HT, Kitai ST. (1985) Projection neurons of the nucleus accumbens: an intracellular labeling study. Brain Res, 347: 112-116.
Chen W, Wu H, Hernandez RJ, Mehta AK, Ticku MK, France CP, Coop A. (2005) Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligands. Bioorg Med Chem Lett, 15: 3201-3202.
Cortez MA, Wu Y, Gibson KM, Snead OC 3rd. (2004) Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy.
Pharmacol Biochem Behav, 79: 547-553.
Cotrina ML, Lin JH, Alves-Rodrigues A, Liu S, Li J, Azmi-Ghadimi H, Kang J, Naus CC, Nedergaard M. (1998) Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci U S A, 95: 15735-15740.
Crunelli V, Emri Z, Leresche N. (2006) Unravelling the brain targets of gamma- hydroxybutyric acid. Curr Opin Pharmacol, 6: 44-52.
Cruz HG, Ivanova T, Lunn ML, Stoffel M, Slesinger PA, Lüscher C. (2004) Bi- directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system. Nat Neurosci, 7: 153-159.
Di Chiara G, Imperato A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
Proc Natl Acad Sci U S A, 85: 5274-5278.
Doherty JD, Snead OC 3rd, Roth RH. (1975) A sensitive method for quantitation of gamma-hydroxybutyric acid and gamma-butyrolactone in brain by electron capture gas chromatography. Anal Biochem, 69: 268-277.
Dresen S, Kempf J, Weinmann W. (2007) Prevalence of g-hydroxybutyrate (GHB) in serum samples of amphetamine, metamphetamine and ecstasy impaired drivers.
Forensic Sci Int 173: 112-116.
Duan S, Anderson CM, Keung EC, Chen Y, Chen Y, Swanson RA. (2003) P2X7 receptor-mediated release of excitatory amino acids from astrocytes. J Neurosci, 23:
1320-1328.
ElSohly MA, Salamone SJ. (1999) Prevalence of drugs used in cases of alleged sexual assault. J Anal Toxicol, 23: 141-146.
Emri Zs, Antal K, Crunelli V. (1996) Gamma-hydroxybutyric acid decreases thalamic sensory excitatory postsynaptic potentials by an action on presynaptic GABAB receptors. Neurosci Lett, 216: 121-124.
Feigenbaum JJ, Howard SG. (1996) Gamma hydroxybutyrate is not a GABA agonist. Prog Neurobiol, 50: 1-7.
Fellin T, D'Ascenzo M, Haydon PG. (2007) Astrocytes control neuronal excitability in the nucleus accumbens. ScientificWorldJournal, 7: 89-97.
Fiacco TA, Agulhon C, Taves SR, Petravicz J, Casper KB, Dong X, Chen J McCarthy KD. (2007) Selective stimulation of astrocyte calcium in situ does not affect neuronal excitatory synaptic activity. Neuron, 54: 611-626.
Fields RD, Stevens-Graham B. (2002) New insights into neuron-glia communication.
Science, 298: 556-562.
Finkbeiner S. (1992) Calcium waves in astrocytes-filling in the gaps. Neuron, 8:
1101-1108.
Fishbein WN, Bessman SP. (1966) Purification and properties of an enzyme in human blood and rat liver microsomes catalyzing the formation and hydrolysis of gamma-lactones. I. Tissue localization, stoichiometry, specificity, distinction from esterase. J Biol Chem, 241: 4835-4841.
Fox CA, Andrade AN, Lu Qui I.J, Rafols JA.(1974) The primate globus pallidus: a Golgi and electron microscopic study. J Hirnforsch, 15: 75-93.
Franke H, Krügel U, Grosche J, Heine C, Härtig W, Allgaier C, Illes P. (2004) P2Y receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience, 127: 431-441.
Franke H, Krügel U, Schmidt R, Grosche J, Reichenbach A, Illes P. (2001) P2 receptor-types involved in astrogliosis in vivo. Br J Pharmacol, 134: 1180-1189.
Gallimberti L, Cibin M, Pagnin P, Sabbion R, Pani PP, Pirastu R, Ferrara SD, Gessa GL. (1993) Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology, 9: 77-81.
Galloway GP, Frederick SL, Staggers FE Jr, Gonzales M, Stalcup SA, Smith DE.
(1997) Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction, 92: 1035-1036.
Gao B, Kilic E, Baumann CR, Hermann DM, Bassetti CL. (2008) Gamma- hydroxybutyrate accelerates functional recovery after focal cerebral ischemia.
Cerebrovasc Dis, 26: 413-419.
Gervasi N, Monnier Z, Vincent P, Paupardin-Tritsch D, Hughes SW, Crunelli V, Leresche N. (2003) Pathway-specific action of gamma-hydroxybutyric acid in sensory thalamus and its relevance to absence seizures. J Neurosci, 23: 11469-11478.
Gervasi N, Monnier Z, Vincent P, Paupardin-Tritsch D, Hughes SW, Crunelli V, Leresche N. (2003) Pathway-specific action of gamma-hydroxybutyric acid in sensory thalamus and its relevance to absence seizures. J Neurosci, 23: 11469-11478.
Gessa GL. (1990) Guidelines for the drug therapy of alcoholism. Recenti Prog Med, 81: 171-175.
Gold BI, Roth RH. (1977) Kinetics of in vivo conversion of gamma- [3H]aminobutyric acid to gamma-[3H]hydroxybutyric acid by rat brain. J Neurochem, 28: 1069-1073.
Gould GG, Mehta AK, Frazer A, Ticku MK. (2003) Quantitative autoradiographic analysis of the new radioligand [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H- benzo[a][7]annulen-6-ylidene) ethanoic acid ([(3)H] NCS-382) at gamma- hydroxybutyric acid (GHB) binding sites in rat brain. Brain Res, 979: 51–56.
Groenewegen HJ, Russchen FT. (1984) Organization of the efferent projections of the nucleus accumbens to pallidal, hypothalamic, and mesencephalic structures: a tracing and immunohistochemical study in the cat. J Comp Neurol, 223: 347-367.
Hajós F. (1975) An improved method for the preparation of synaptosomal fractions in high purity. Brain Res, 93: 485–489.
Harris-White ME, Zanotti SA, Frautschy SA, Charles AC. (1998) Spiral intercellular calcium waves in hippocampal slice cultures. J Neurophysiol, 79: 1045-1052.
Hassinger TD, Guthrie PB, Atkinson PB, Bennett MV, Kater SB. (1996) An extracellular signaling component in propagation of astrocytic calcium waves. Proc Natl Acad Sci U S A, 93: 13268-13273.
Haydon PG. (2001) GLIA: listening and talking to the synapse. Nat Rev Neurosci, 2:
185–193.
Hakak Y, Lehmann-Bruinsma K, Phillips S, Le T, Liaw C, Connolly DT, Behan DP.
(2009) The role of the GPR91 ligand succinate in hematopoiesis. J Leukoc Biol, Epub: Feb 9. doi: 10.1189/jlb.1008618.
He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, Chen JL, Tian H, Ling L.
(2004) Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature, 429: 188-193.
Hechler V, Gobaille S, Maitre M. (1992) Selective distribution pattern of gamma- hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography. Brain Res, 572: 345-348.
Hechler V, Ratomponirina C, Maitre M. (1997) Gamma-Hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide. J Pharmacol Exp Ther, 281: 753-760.
Hems DA, Brosnan JT. (1970) Effects of ischaemia on content of metabolites in rat liver and kidney in vivo. Biochem J, 120: 105–111.
Héja L, Kovács I, Szárics É, Incze M, Temesváriné Major E, Dörnyei G, Peredy- Kajtár M, Gács-Baitz E, Szántay Cs, Kardos J. (2004) Novel secoergoline derivatives inhibit both GABA and glutamate uptake in rat brain homogenates:
synthesis, in vitro pharmacology and modeling. J Med Chem, 47: 5620-5629.
Hirase H. (2005) A multi-photon window onto neuronal-glial-vascular communication. Trends Neurosci, 28: 217-219.
Inoue K, Fei YJ, Zhuang L, Gopal E, Miyauchi S, Ganapathy V. (2004) Functional features and genomic organization of mouse NaT, a sodium- coupled transporter for tricarboxylic acid cycle intermediates. Biochem J, 378: 949–957.
Inoue K, Zhuang L, Ganapathy V. (2002a) Human Na1-coupled citrate transporter:
primary structure, genomic organization, and transport function. Biochem Biophys Res Commun, 299: 465–471.
Inoue K, Zhuang L, Maddox DM, Smith SB, Ganapathy V. (2002b) Structure, function, and expression pattern of a novel sodium-coupled citrate transporter (NaT) cloned from mammalian brain. J Biol Chem, 277: 39469–39476.
Jakobs C, Bojasch M, Mönch E, Rating D, Siemes H, Hanefeld F. (1981) Urinary excretion of gamma-hydroxybutyric acid in a patient with neurological abnormalities. The probability of a new inborn error of metabolism. Clin Chim Acta, 111: 169-178.
Jakobs C, Smit LM, Kneer J, Michael T, Gibson KM. (1990) The first adult case with 4-hydroxybutyric aciduria. J Inherit Metab Dis, 13: 341-344.
Jensen K, Mody I. (2001) GHB depresses fast excitatory and inhibitory synaptic transmission via GABA(B) receptors in mouse neocortical neurons. Cereb Cortex, 11: 424-429.
Jones C. (2001) Suspicious death related to gamma-hydroxybutyrate (GHB) toxicity.
J Clin Forensic Med, 8: 74-76.
Kafitz KW, Meier SD, Stephan J, Rose CR. (2008) Developmental profile and properties of sulforhodamine 101-labeled glial cells in acute brain slices of rat hippocampus. J Neurosci Methods, 169: 84-92.
Kang J, Kang N, Lovatt D, Torres A, Zhao Z, Lin J, Nedergaard M. (2008) Connexin 43 hemichannels are permeable to ATP. J Neurosci, 28: 4702-4711.
Kankaanpa A, Liukkonen R, Ariniemi K. (2007) Determination of gamma- hydroxybutyrate (GHB) and its precursors in blood and urine samples: A salting-out approach. Forensic Sci Int, 170: 133–138.
Kardos J, Hajós F, Simonyi M. (1984) Differential localization of GABA-dependent and GABA-independent benzodiazepine binding sites within synapses of rat cerebral cortex. Neurosci Lett, 48: 355–359.
Kaufman EE, Nelson T, Miller D, Stadlan N. (1988) Oxidation of gamma- hydroxybutyrate to succinic semialdehyde by a mitochondrial pyridine nucleotide- independent enzyme. J Neurochem, 51: 1079-1084.
Kaufman EE, Nelson T. (1981) Kinetics of coupled gamma-hydroxybutyrate oxidation and D-glucuronate reduction by an NADP+-dependent oxidoreductase. J Biol Chem, 256: 6890-6894.
Kaufman EE, Nelson T. (1987) Evidence for the participation of a cytosolic NADP+- dependent oxidoreductase in the catabolism of gamma-hydroxybutyrate in vivo. J Neurochem, 48: 1935-1941.
Kaufman EE, Relkin N, Nelson T. (1987) Regulation and properties of an NADP+ oxidoreductase which functions as a gamma-hydroxybutyrate dehydrogenase. J Neurochem, 40: 1639-1646.
Kaupmann K, Cryan JF, Wellendorph P, Mombereau C, Sansig G, Klebs K, Schmutz M, Froestl W, van der Putten H, Mosbacher J, Bräuner-Osborne H, Waldmeier P, Bettler B. (2003) Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.
Eur J Neurosci, 18: 2722-2730.
Knudsen K, Greter J, Verdicchio M, Cederquist T. (2005) GHB, GBL and butanediol poisonings-a serious problem in Western Sweden. Lakartidningen, 102: 3294-3296.
Krebs HA. (1950) Chemical composition of blood plasma and serum. Annu Rev Biochem, 19: 409-430.
Laborit H, Jouany JM, Gerard J, Fabiani F. (1960) Generalities concerning the experimental study and clinical use of gamma hydroxybutyrate. Agressologie, 1:
397-406.
Levy MI, Davis BM, Mohs RC, Trigos GC, Mathé AA, Davis KL. (1983) Gamma- hydroxybutyrate in the treatment of schizophrenia. Psychiatry Res, 9: 1-8.
Li Q, Kuhn CM, Wilson WA, Lewis DV. (2007) Effects of gamma hydroxybutyric acid on inhibition and excitation in rat neocortex. Neuroscience, 150: 82-92.
Lingenhoehl K, Brom R, Heid J, Beck P, Froestl W, Kaupmann K, Bettler B, Mosbacher J. (1999) Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. Neuropharmacology, 38: 1667-1673.
MacMillan V. (1979) A comparison of the effects of gamma-hydroxybutyrate and gamma-butyrolactone on cerebral carbohydrate metabolism. Can J Physiol Pharmacol, 57: 787-797.
Madden TE, Johnson SW. (1998) Gamma-hydroxybutyrate is a GABAB receptor agonist that increases a potassium conductance in rat ventral tegmental dopamine neurons. J Pharmacol Exp Ther, 287: 261-265.
Maitre M, Cash C, Weissmann-Nanopoulos D, Mandel P. (1983) Depolarization- evoked release of gamma-hydroxybutyrate from rat brain slices. J Neurochem, 41:
287-290.
Maitre M. (1997) The gamma-hydroxybutyrate signalling system in brain:
organization and functional implications. Prog Neurobiol, 51: 337-361.
Mamelak M, Escriu JM, Stokan O. (1977) The effects of gamma hydroxybutyrate on sleep. Biol Psychiatry, 12: 273-288.
Mamelak M. (1989) Gamma-hydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci Biobehav Rev, 13: 187-198.
Mangiavacchi S, Wolf ME. (2004) Stimulation of N-methyl-D-aspartate receptors, AMPA receptors or metabotropic glutamate receptors leads to rapid internalization of AMPA receptors in cultured nucleus accumbens neurons. Eur J Neurosci, 20: 649- 657.
Martellotta MC, Balducci C, Fattore L, Cossu G, Gessa GL, Pulvirenti L, Fratta W.
(1998) Gamma-hydroxybutyric acid decreases intravenous cocaine self- administration in rats. Pharmacol Biochem Behav, 59: 697-702.
Mathivet P, Bernasconi R, De Barry J, Marescaux C, Bittiger H. (1997) Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB
receptor agonist. Eur J Pharmacol, 321: 67-75.
Matthias K, Kirchhoff F, Seifert G, Huttmann K, Matyash M, Kettenmann H, Steinhauser C. (2003) Segregated expression of AMPA-type glutamate receptors and glutamate transporters defines distinct astrocyte populations in the mouse hippocampus. J Neurosci, 23: 1750-1758.
McCracken CB, Hamby SM, Patel KM, Morgan D, Vrana KE, Roberts DC. (2005) Extended cocaine self-administration and deprivation produces region-specific and time-dependent changes in connexin36 expression in rat brain. Synapse, 58: 141- 150.
Mehta AK, Muschaweck NM, Maeda DY, Coop A, Ticku MK. (2001) Binding characteristics of the gamma-hydroxybutyric acid receptor antagonist [3H](2E)-(5- hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid in the rat brain. J Pharmacol Exp Ther, 299: 1148-1153.
Meredith G, Wouterlood F. Synaptic organization of nucleus accumbens (ventral striatum). Plenum Press, New York 1990: 167-176.
Mogenson GJ, Swanson LW, Wu M. (1983) Neural projections from nucleus accumbens to globus pallidus, substantia innominata, and lateral preoptic-lateral hypothalamic area: an anatomical and electrophysiological investigation in the rat. J Neurosci, 3: 189-202.
Molnár T, Antal K, Emri Z. (2009a) Gamma-Hydroxybutyrate induces GABAB
receptor independent intracellular Ca2+ transients in astrocytes, but has no effect on the GHB or GABAB receptors of medium spiny neurons in the nucleus accumbens.
Neuroscience, 162: 268-281.
Molnár T, Barabás P, Héja L, Fekete EK, Lasztóczi B, Szabó P, Nyitrai G, Simon- Trompler E, Hajós F, Palkovits M, Kardos J. (2008a) Gamma-hydroxybutyrate binds to the synaptic site recognizing succinate monocarboxylate: a new hypothesis on astrocyte-neuron interaction via protonated succinate signaling. J Neurosci Res, 86:
1566-1576.
Molnár T, Kútiné Fekete E, Kardos J, Simon-Trompler E, Palkovits M, Emri Zs.
(2006) Metabolic GHB precursor succinate binds to g-hydroxybutyrate receptors:
characterization of human basal ganglia areas nucleus accumbens and globus pallidus. J Neurosci Res, 84: 27–36.
Molnár T, Visy J, Simon Á, Moldvai I, Temesvári-Major E, Dörnyei G, Fekete EK, Kardos J. (2008b) Validation of high-affinity binding sites for succinic acid through distinguishable binding of gamma-hydroxybutyric acid receptor-specific NCS-382 antipodes. Bioorg Med Chem Lett, 18: 6290-6292.
Narita M, Suzuki M, Kuzumaki N, Miyatake M, Suzuki T. (2008) Implication of activated astrocytes in the development of drug dependence: differences between methamphetamine and morphine. Ann N Y Acad Sci, 1141: 96-104.
Nelson T, Kaufman E, Kline J, Sokoloff L. (1981) The extraneural distribution of gamma-hydroxybutyrate. J Neurochem, 37: 1345-1348.
O'Donnell P, Greene J, Pabello N, Lewis BL, Grace AA. (1999) Modulation of cell firing in the nucleus accumbens. Ann N Y Acad Sci, 877: 157-175.
Onn SP, Grace AA. (1994) Dye coupling between rat striatal neurons recorded in vivo: compartmental organization and modulation by dopamine. J Neurophysiol, 71:
1917-1934.
Onn SP, Grace AA. (2000) Amphetamine withdrawal alters bistable states and cellular coupling in rat prefrontal cortex and nucleus accumbens neurons recorded in vivo. J Neurosci, 20: 2332-2345.
Ottani A, Vergoni AV, Saltini S, Mioni C, Giuliani D, Bartiromo M, Zaffe D, Botticelli AR, Ferrari A, Bertolini A, Genedani S. (2004) Effect of late treatment with gamma-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia in the rat. Eur J Pharmacol, 485: 183-191.
Paemeleire K, Martin PE, Coleman SL, Fogarty KE, Carrington WA, Leybaert L, Tuft RA, Evans WH, Sanderson MJ. (2000) Intercellular calcium waves in HeLa cells expressing GFP-labeled connexin 43, 32, or 26. Mol Biol Cell, 11: 1815-1827.
Pajor AM. (2006) Molecular properties of the SLC13 family of dicarboxylate and sulfate transporters. Pflugers Arch Eur J Physiol, 451: 597–605.
Palkovits M. (1973) Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res, 59: 449–450.
Parri HR, Gould TM, Crunelli V. (2001) Spontaneous astrocytic Ca2+ oscillations in situ drive NMDAR-mediated neuronal excitation. Nat Neurosci, 8: 803-812.
Pasti L, Zonta M, Pozzan T, Vicini S, Carmignoto G. (2001) Cytosolic calcium oscillations in astrocytes may regulate exocytotic release of glutamate. J Neurosci, 21: 477-484.
Peinado A. (2001) Immature neocortical neurons exist as extensive syncitial networks linked by dendrodendritic electrical connections. J Neurophysiol, 85: 620- 629.
Persson SA, Eriksson A, Hallgren N, Eklund A, Berkowicz A, Druid H. (2001) GHB-dangerous, addictive and uncontrollable "party drug”. Lakartidningen, 98:
4026-4031.
Pistis M, Muntoni AL, Pillolla G, Perra S, Cignarella G, Melis M, Gessa GL. (2005) Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit:
evidence for GABA(B) receptor-mediated effects. Neuroscience, 131: 465-474.
Poldrugo F, Addolorato G. (1999) The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies. Alcohol Alcohol, 34: 15-24.
Rahbeeni Z, Ozand PT, Rashed M, Gascon GG, al Nasser M, al Odaib A, Amoudi M, Nester M, al Garawi S, Brismar J. (1994) 4-Hydroxybutyric aciduria. Brain Dev, 16 Suppl: 64-71.
Ren X, Mody I. (2003) Gamma-hydroxybutyrate reduces mitogen-activated protein kinase phosphorylation via GABA B receptor activation in mouse frontal cortex and hippocampus. J Biol Chem, 278: 42006-42011.
Robinson TE, Gorny G, Mitton E, Kolb B. (2001) Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse, 39: 257-266.
Robinson TE, Kolb B. (2004) Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology, 47 Suppl 1: 33-46.
Rubic T, Lametschwandtner G, Jost S, Hinteregger S, Kund J, Carballido-Perrig N, Schwärzler C, Junt T, Voshol H, Meingassner JG, Mao X, Werner G, Rot A, Carballido JM. (2008) Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol, 9: 1261-1269.
Rumigny JF, Cash C, Mandel P, Vincendon G, Maitre M. (1981) Evidence that a specific succinic semialdehyde reductase is responsible for gamma-hydroxybutyrate synthesis in brain tissue slices. FEBS Lett, 134: 96-98.
Rumigny JF, Maitre M, Cash C, Mandel P. Regional and subcellular localization in rat brain of the enzymes that can synthesize gamma-hydroxybutyric acid. J Neurochem, 36: 1433-1438.
Sadasivan S, Maher TJ, Quang LS. (2006) Gamma-Hydroxybutyrate (GHB), gamma butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion. Ann N Y Acad Sci, 1074: 537-544.
Sanderson MJ, Charles AC, Dirksen ER. (1990) Mechanical stimulation and intercellular communication increases intracellular Ca2+ in epithelial cells. Cell Regul, 1: 585-596.
Sanderson MJ. (1995) Intercellular calcium waves mediated by inositol trisphosphate. Ciba Found Symp, 188: 175-189.
Santaniello E, Manzocchi A, Tosi L. (1978) Evaluation of gamma-hydroxybutyrate formed from L-glutamate by mouse brain homogenate. J Neurochem, 31: 1117-1118.
Santello M, Volterra A. (2009) Synaptic modulation by astrocytes via Ca2+- dependent glutamate release. Neuroscience, 158: 253-259.
Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, Cho JH, Honoré JC, Kermorvant-Duchemin E, Varma DR, Tremblay S, Leduc M, Rihakova L, Hardy P, Klein WH, Mu X, Mamer O, Lachapelle P, Di Polo A, Beauséjour C, Andelfinger G, Mitchell G, Sennlaub F, Chemtob S. (2008) The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med, 14: 1067-1076.
Scharf MB, Fletcher KA. (1989) GHB-new hope for narcoleptics? Biol Psychiatry, 26: 329-330.
Schipke CG, Boucsein C, Ohlemeyer C, Kirchhoff F, Kettenmann H. (2002) Astrocyte Ca2+ waves trigger responses in microglial cells in brain slices. FASEB J, 16: 255-257.
Schousboe A, Saito K, Wu JY. (1980) Characterization and cellular and subcellular localization of GABA-transaminase. Brain Res Bull, 5: 71-76.
Schousboe A, Waagepetersen HS. (2006) Glial modulation of GABAergic and glutamat ergic neurotransmission. Curr Top Med Chem, 6: 929-934.
Schuler V, Lüscher C, Blanchet C, Klix N, Sansig G, Klebs K, Schmutz M, Heid J, Gentry C, Urban L, Fox A, Spooren W, Jaton AL, Vigouret J, Pozza M, Kelly PH,